Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (1932)	9/30/1997 11:03:00 AM
From: Paul Barr	of 6136

Henry, The resistance profile should not have been news to you, if you follow the AIDS drugs environment at all. At least 5-10% of AIDS patients are resistance to all PI's. VIRACEPT provides a better side affect profile then most othe PI's and their resistance is said to be a bit better then the other PI's. All of this is pretty common news, I find it surprising that you haven't heard of these things. If you want, I can give you some websites that provide excellent information on the AIDS PI category. Paul PS. I don't believe in conspiracies either.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next